Salim Yazji

976 citations
29 papers · 738 indexed · h-index 12
Topics
Lymphoma Diagnosis and Treatment (5 papers)Macrophage Migration Inhibitory Factor (5 papers)Peptidase Inhibition and Analysis (4 papers)

In The Last Decade

Salim Yazji

28 papers receiving 719 citations

Peers

Salim Yazji
Comparison fields: 5 of 59
  • Oncology 303
  • Molecular Biology 220
  • Pathology and Forensic Medicine 186
  • Pulmonary and Respiratory Medicine 155
  • Immunology 153
Replace John Galbincea with:
John Galbincea United States
Mark Biondo Australia
Carlos Barranco Spain
Simon Tickle United Kingdom
Jason W. Bauer United States
Pia Klausen Denmark
Alexandra S. Worobec United States
Yasumasa Monobe Japan
H Steininger Germany
Gerrie Stoeken‐Rijsbergen Netherlands
Salim Yazji relative to John Galbincea United States John Galbincea's profile →
Citations per field
00.5×1.5×2.3×
John Galbincea · 1×
Citations per year

Countries citing papers authored by Salim Yazji

Since Specialization
Citations

This map shows the geographic impact of Salim Yazji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salim Yazji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salim Yazji more than expected).

Fields of papers citing papers by Salim Yazji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salim Yazji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salim Yazji. The network helps show where Salim Yazji may publish in the future.

Co-authorship network of co-authors of Salim Yazji

This figure shows the co-authorship network connecting the top 25 collaborators of Salim Yazji. A scholar is included among the top collaborators of Salim Yazji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salim Yazji. Salim Yazji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 2
5 5
6 62
7 3
8 1
9 97
10 18
11 25
12 130
13 16
14 9
15 4
16 26
17 65
18 52
19 42
20 120

About Salim Yazji

Salim Yazji is a scholar working on Immunology and Allergy, Immunology and Oncology, having authored 29 papers that have together received 738 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Macrophage Migration Inhibitory Factor (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Gastroenterology (108 citations), Immunology and Allergy (105 citations) and Hematology (128 citations). Salim Yazji has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Francis J. Giles, Alejandro D. Ricart, Geoffrey R. Weiss, Glenn Liu, George Wilding, Anthony W. Tolcher, Kyle D. Holen, Chee M. Ng, Garry Schwartz and Mark R. Albertini. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026